Press Release - Company Data

AmDerma Pharmaceuticals Exercises Option to License Rights to Oculus Innovative Sciences Microcyn(R)-Based Acne Drug Candidate
Posted 2011-06-28 10:16NAI500 Admin
,a commercial healthcare company that designs, produces and markets safe and effective tissue care products based upon the Microcyn(R) Technology platform, announced today that AmDerma Pharmaceuticals

Oculus Innovative Sciences Launches Microcyn(R)-Compatible XuSorb(TM) Foam with Waterproof Cover Wound Dressing
Posted 2010-11-10 10:27NAI500 Admin
, a commercial medical technology company that designs, produces and markets safe and effective tissue care products based upon the Microcyn(R) Technology platform, today introduced XuSorb(TM) Foam Wo

Oculus Innovative Sciences to Present at the Rodman & Renshaw 12th Annual Healthcare Conference on September 14 in New York City
Posted 2010-09-08 09:57NAI500 Admin
,a commercial medical technology company that designs, produces and markets safe and effective tissue care products based upon the Microcyn(R) Technology platform, announced today it will present at t

LifeTech Capital Initiates Research Coverage of Oculus Innovative Sciences
Posted 2010-06-24 10:49NAI500 Admin
,a commercial medical technology company that designs, produces and markets safe and effective tissue care products based upon the Microcyn(R) Technology platform, today announced the availability of

Oculus Innovative Sciences Launches Microcyn(R) Negative-Pressure Wound Therapy Solution for U.S. Market
Posted 2010-06-02 09:15NAI500 Admin
,a commercial medical technology company that designs, produces and markets safe and effective tissue care products based upon the Microcyn(R) Technology platform, today introduced the Microcyn Negati

Oculus Innovative Sciences Updates Business Milestones
Posted 2010-05-18 08:54NAI500 Admin
,a commercial medical technology company that designs, produces and markets safe and effective tissue care products based upon the Microcyn(R) Technology platform, today provided an update on its prev

Oculus Innovative Sciences Launches Microcyn(R) Dermatology HydroGel for Relief of Pain and Itch into U.S. Dermatology Healthcare Market
Posted 2010-03-25 09:09NAI500 Admin
,a commercial medical technology company that designs, produces and markets safe and effective tissue care products based upon the Microcyn(R) Technology platform, today commercially introduced the Mi

Oculus Innovative Sciences Introduces Microcyn(R) Solution for Use in Post-Surgical Wounds to U.S. Hospitals and Physicians
Posted 2010-01-28 18:19NAI500 Admin
a commercial medical technology company that designs, produces and markets safe and effective tissue care products based upon the Microcyn(R) Technology platform, today unveiled Microcyn Solution wit

Oculus Innovative Sciences to Present at OneMed Forum 2010 During JP Morgan Week in San Francisco
Posted 2010-01-07 11:01NAI500 Admin
today announced that Hoji Alimi, the company's CEO and founder, will discuss the upcoming 2010 regulatory and commercial milestones during his presentation at the OneMed Forum 2010 to be held at the

Oculus Innovative Sciences Provides 2010 U.S. Milestones Update
Posted 2009-12-03 12:18NAI500 Admin
--Orthopedic and Surgical -- Microcyn Technology Product Introduction into Orthopedic and Surgical Markets (Jan. 2010)